The name of the game is volume. The more volume a drug company has with a particular PBM, and the greater the drug company's market share, the better the potential deal that the drug company can offer as an inducement to disfavor rival drugs.
Warren discusses how PBMs create incentives that favor larger drug companies over competitors.
Share
More from Elizabeth Warren
I’m pretty outraged that you drag in billions of dollars from taxpayers and that you won’t submit to an audit when it’s clear that you have the opportunity to bilk the federal government and you have used that opportunity in other…
“Trump’s FCC Chair is trying to illegally rewrite the rules to make it easier for billionaires to line their own pockets while jacking up costs and controlling what Americans watch. After rubber-stamping the Nexstar-Tegna megamerger, this…
If DOD wants to use a PBM, get one that works exclusively for DOD and American taxpayers – and not one that works simultaneously to increase profits for its parent insurance company.
That is a clear conflict of interest. And yet, DOD actually requires the TRICARE pharmacy contractor to own both a PBM and a pharmacy. I don’t know who talked them into that, but it is an open invitation for Express Scripts to milk the…
Other voices in this conversation
